Complete response to sunitinib in a patient with relapsed irresectable renal cell carcinoma

被引：4

作者：

Angeles Vaz, Maria ^{[1
]}

Pachon, Vanessa ^{[1
]}

Grande, Enrique ^{[1
]}

Ferreiro, Reyes ^{[1
]}

Carrato, Alfredo ^{[1
]}

机构：

[1] Ramon y Cajal Univ Hosp, Dept Med Oncol, Madrid, Spain

来源：

ANTI-CANCER DRUGS | 2011年 / 22卷 / 08期

关键词：

complete response; renal cell carcinoma; sunitinib; tyrosine kinase inhibitors; INTERFERON-ALPHA; SURVIVAL; THERAPY; CANCER; MANAGEMENT; RESECTION;

D O I：

10.1097/CAD.0b013e3283437ff9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We report a case with a complete pathology-proven remission after sunitinib treatment of a relapsed irresectable clear cell renal carcinoma. A significant objective response was observed with tumor size reduction during treatment. After surgery, on pathologic examination it was concluded that the patient exhibited a complete response; activity and the feasibility and safety of subsequent surgical resection were assessed. Otherwise after discontinuing sunitinib, the patient had a relapse on the same location; sunitinib has been resumed and was again found to be effective. Anti-Cancer Drugs 22:817-821 (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.

引用

页码：817 / 821

页数：5

共 27 条

[1] Preoperative tyrosine kinase inhibition as an adjunct to debulking nephrectomy [J].

Amin, Chirag ;

Wallen, Eric ;

Pruthi, Raj S. ;

Calvo, Benjamin F. ;

Godley, Paul A. ;

Rathmell, W. Kimryn .

UROLOGY, 2008, 72 (04) :864-868

[2] Management of advanced renal cancer [J].

Atkins, M .

KIDNEY INTERNATIONAL, 2005, 67 (05) :2069-2082

[3] Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial [J].

Escudier, Bernard ;

Pluzanska, Anna ;

Koralewski, Piotr ;

Ravaud, Alain ;

Bracarda, Sergio ;

Szczylik, Cezary ;

Chevreau, Christine ;

Filipek, Marek ;

Melichar, Bohuslav ;

Bajetta, Emilio ;

Gorbunova, Vera ;

Bay, Jacques-Olivier ;

Bodrogi, Istvan ;

Jagiello-Gruszfeld, Agnieszka ;

Moore, Nicola .

LANCET, 2007, 370 (9605) :2103-2111

[4] Sorafenib in advanced clear-cell renal-cell carcinoma [J].

Escudier, Bernard ;

Eisen, Tim ;

Stadler, Walter M. ;

Szczylik, Cezary ;

Oudard, Stephane ;

Siebels, Michael ;

Negrier, Sylvie ;

Chevreau, Christine ;

Solska, Ewa ;

Desai, Apurva A. ;

Rolland, Frederic ;

Demkow, Tomasz ;

Hutson, Thomas E. ;

Gore, Martin ;

Freeman, Scott ;

Schwartz, Brian ;

Shan, Minghua ;

Simantov, Ronit ;

Bukowski, Ronald M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :125-134

[5]

Escudier B, 2010, EXPERT REV ANTICANC, V10, P305, DOI [10.1586/era.10.26, 10.1586/ERA.10.26]

[6] Prolonged complete responses and near-complete responses to sunitinib in metastatic renal cell carcinoma [J].

Heng, Daniel Y. C. ;

Rini, Brian I. ;

Garcia, Jorge ;

Wood, Laura ;

Bukowsk, Ronald M. .

CLINICAL GENITOURINARY CANCER, 2007, 5 (07) :446-451

[7] AN ASSESSMENT OF THE CURRENT USE OF HUMAN INTERFERONS IN THERAPY OF UROLOGICAL CANCERS [J].

HOROSZEWICZ, JS ;

MURPHY, GP .

JOURNAL OF UROLOGY, 1989, 142 (05) :1173-1180

[8] Cancer statistics, 2008 [J].

Jemal, Ahmedin ;

Siegel, Rebecca ;

Ward, Elizabeth ;

Hao, Yongping ;

Xu, Jiaquan ;

Murray, Taylor ;

Thun, Michael J. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2008, 58 (02) :71-96

[9] Can Tyrosine Kinase inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis [J].

Johannsen, Manfred ;

Floercken, Anne ;

Bex, Axel ;

Roigas, Jan ;

Cosentino, Marco ;

Ficarra, Vincenzo ;

Kloeters, Christian ;

Rief, Matthias ;

Rogalla, Patrik ;

Miller, Kurt ;

Gruenwald, Viktor .

EUROPEAN UROLOGY, 2009, 55 (06) :1430-1439

[10] The von Hippel-Lindau tumor suppressor gene [J].

Kondo, K ;

Kaelin, WG .

EXPERIMENTAL CELL RESEARCH, 2001, 264 (01) :117-125

← 1 2 3 →